VTGN icon

VistaGen Therapeutics
VTGN

Overview Fund Activity

25 hedge funds and large institutions have $7.99M invested in VistaGen Therapeutics in 2019 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 7 closing their positions.

Holders
25
Holders Change
+4
Holders Change %
+19.05%
% of All Funds
0.54%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
4
Reduced
1
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Point72 Asset Management
1
Point72 Asset Management
Connecticut
$1.66M
2
SFM
2
Sphera Funds Management
Israel
$2.59M
3
PVI
3
Pura Vida Investments
New York
$544K
4
Vanguard Group
4
Vanguard Group
Pennsylvania
$1.49M
5
ECM
5
Endurant Capital Management
California
$462K

Top Sellers

1
II
1
Ibex Investors
Colorado
$0
2
OAM
2
Oxford Asset Management
United Kingdom
$0
3
Millennium Management
3
Millennium Management
New York
$0
4
UBS Group
4
UBS Group
Switzerland
$0
5
CPA
5
Cowen Prime Advisors
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
II
26
Ibex Investors
Colorado
– -$270K -6,000 Closed
OAM
27
Oxford Asset Management
United Kingdom
– -$39K -872 Closed
Millennium Management
28
Millennium Management
New York
– -$28K -621 Closed
UBS Group
29
UBS Group
Switzerland
– -$13K -278 Closed
CPA
30
Cowen Prime Advisors
New York
– -$4K -80 Closed
WOC
31
West Oak Capital
California
– -$750 -17 Closed
1
2